thiophenes has been researched along with Cirrhoses, Experimental Liver in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aihara, Y; Asada, K; Douhara, A; Kawaratani, H; Kitade, M; Moriya, K; Namisaki, T; Nishimura, N; Noguchi, R; Okura, Y; Takeda, K; Yoshiji, H | 1 |
Ahn, CY; Bae, SH; Bae, SK; Jung, YS; Kim, T; Kim, YC; Lee, MG; Shin, WG | 1 |
Bae, SK; Cho, MK; Kang, KW; Kim, CW; Kim, SG; Kim, YG; Lee, MG | 1 |
Bae, SK; Kim, SG; Lee, I; Lee, JY; Lee, MG; Lee, SJ; Lee, Y | 1 |
Ercan, F; Gedik, N; Sehirli, AO; Sener, G; Toklu, HZ; Yuksel, M | 1 |
Choi, SH; Ha, JR; Kang, KW; Kim, CW; Kim, SG | 1 |
6 other study(ies) available for thiophenes and Cirrhoses, Experimental Liver
Article | Year |
---|---|
Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.
Topics: Animals; Body Weight; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glucosides; Hepatic Stellate Cells; Hypoglycemic Agents; Insulin Resistance; Liver; Liver Cirrhosis, Experimental; Male; Obesity; Organ Size; Rats, Inbred OLETF; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2016 |
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
Topics: Animals; Area Under Curve; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Liver; Liver Cirrhosis, Experimental; Pyrazines; Rats; Schistosomicides; Thiones; Thiophenes | 2009 |
Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation.
Topics: Animals; CCAAT-Enhancer-Binding Proteins; Extracellular Matrix; Liver; Liver Cirrhosis, Experimental; Liver Regeneration; Models, Biological; Pyrazines; Rats; RNA, Messenger; Survival Analysis; Thiones; Thiophenes; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
Topics: Administration, Oral; Animals; Area Under Curve; Blood Proteins; Dimethylnitrosamine; Injections, Intravenous; Liver Cirrhosis, Experimental; Male; Microsomes, Liver; Protein Binding; Pyrazines; Rats; Rats, Sprague-Dawley; Schistosomicides; Thiones; Thiophenes; Time Factors; Tissue Distribution | 2004 |
Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cytokines; Expectorants; Glutathione; L-Lactate Dehydrogenase; Liver; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Microbial Collagenase; Oxidative Stress; Peroxidase; Rats; Thioglycolates; Thiophenes | 2007 |
Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-beta1 and tumor necrosis factor-alpha expression.
Topics: Animals; Base Sequence; Dimethylnitrosamine; DNA Primers; Glyceraldehyde-3-Phosphate Dehydrogenases; Liver Cirrhosis, Experimental; Pyrazines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiones; Thiophenes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2002 |